Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infectionLaura Tarancón‐Díez, Francesc Vidal, Esther Rodríguez‐Gallego et al.|EBioMedicine|2019Cited by 81
A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patientsEsther Rodríguez‐Gallego, Francesc Vidal, Josep Gómez et al.|AIDS|2017Cited by 42
Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite ControlEsther Rodríguez‐Gallego, Ezequiel Ruíz-Mateos, Laura Tarancón‐Díez et al.|The Journal of Infectious Diseases|2018Cited by 31
High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patientsElena Yeregui, Anna Rull, Consuelo Viladés et al.|EBioMedicine|2020Cited by 30
Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)Consuelo Viladés, Lander Egaña-Gorrondo, Xavier Escoté et al.|Journal of Antimicrobial Chemotherapy|2014Cited by 22